Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09KTI
|
|||
| Former ID |
DNCL003551
|
|||
| Drug Name |
GS-5816
|
|||
| Indication | Chronic HCV-1 infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 2 | [1] | |
| Company |
GILEAD
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C49H54N8O8
|
|||
| Canonical SMILES |
CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC
|
|||
| InChI |
1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1
|
|||
| InChIKey |
FHCUMDQMBHQXKK-CDIODLITSA-N
|
|||
| CAS Number |
CAS 1377049-84-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:133009
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02336139) A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.